Related News:
- Roche announces the European Commission approval of…
- FDA approves Roche’s Vabysmo, the first bispecific…
- FDA approves Roche’s Vabysmo, the first bispecific…
- FDA approves Roche’s Lunsumio, a first-in-class…
- Five-year results confirm Roche’s Polivy combination…
- FDA grants priority review to Xolair (omalizumab)…